Systemic Hemodynamic Abnormalities and Vasopressor Therapy in Sepsis and Septic Shock
- 1 September 1992
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 20 (3) , 214-222
- https://doi.org/10.1016/s0272-6386(12)80693-7
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Experience with phenylephrine as a component of the pharmacologie support of septic shockCritical Care Medicine, 1991
- Interleukin-1 receptor antagonist reduces mortality from endotoxin shockNature, 1990
- The Cardiovascular Response of Normal Humans to the Administration of EndotoxinNew England Journal of Medicine, 1989
- Norepinephrine therapy has no deleterious renal effects in human septic shockCritical Care Medicine, 1989
- Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock.The Journal of Experimental Medicine, 1989
- Detection of Circulating Tumor Necrosis Factor after Endotoxin AdministrationNew England Journal of Medicine, 1988
- Gram-negative bacteremia produces both severe systolic and diastolic cardiac dysfunction in a canine model that simulates human septic shock.Journal of Clinical Investigation, 1986
- Norepinephrine alone versus norepinephrine plus low-dose dopamineCritical Care Medicine, 1985
- Treatment of Gram-Negative Bacteremia and Shock with Human Antiserum to a MutantEscherichia coliNew England Journal of Medicine, 1982
- Ibuprofen in canine endotoxin shock.Journal of Clinical Investigation, 1982